Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin

AIM: Assess the pharmacodynamics of lixisenatide once daily (QD) versus liraglutide QD in type 2 diabetes insufficiently controlled on metformin. METHODS: In this 28-day, randomized, open-label, parallel-group, multicentre study (NCT01175473), patients (mean HbA1c 7.3%) received subcutaneous lixisen...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kapitza, C, Forst, T, Coester, H-V, Poitiers, F, Ruus, P, Hincelin-Méry, A
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2013
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752965/
https://ncbi.nlm.nih.gov/pubmed/23368510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12076
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky